Answers are grounded in this paper and cite their sources.
Raltitrexed (Tomudex), a classical folate antagonist, is a selective inhibitor of thymidylate synthase (TS). It has significant single-agent activity in metastatic colorectal cancer. Severe life-threatening toxicity related to the administration of 5-fluorouracil and leucovorin is described in two patients, both of whom were not deficient in dihydropyrimidine dehydrogenase. Raltitrexed was administered to both patients with clinically acceptable side effects and allowed a TS inhibitor to be administered as part of an adjuvant program.
No takes yet. Share an insight, caveat, or question.
Kempin et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: